The Economic Times
English EditionEnglish Editionहिन्दीગુજરાતી
| 15 July, 2020, 11:21 PM IST | E-Paper

    Teena Thacker

    Staff Reporter, ET

    Articles by the author

    Empowered committee to discuss proposal to allow export of ‘covid care’ medical devicesModerna's Covid vaccine shows promise, to enter final stage of human trials this monthGovernment lab starts testing Oxford’s vaccine candidate to determine its sterilityRemdesivir makers told to ramp up production by the department of pharmaceuticals
    Drug regulator okays psoriasis injection for limited use in treating COVID-19 patientsMake first serosurvey data public: ExpertsCovid-19 takes a toll on mental health of manyNPPA asks Remdisivir drug makers to ensure transparency after complaints about black marketing
    Pricing regulator asks pharma companies to provide stock details to ensure availability of drugsDrug companies complain of hefty charges on stuck consignments from ChinaAIIMS, Vizag Hospital yet to approve trials of locally-made Covid vaccineTwo weeks to start the trial, six months at least to finish: Experts
    WHO ending hydroxycholorquine trial for COVIDICMR says move to fast-track COVID-19 vaccine is in accordance with global normsExperts in two minds over ICMR's August 15 date for Covid-19 vaccine launchICMR-Bharat Biotech COVID-19 vaccine trial results to be released by Aug 15
    Gilead won't launch its Covid drug in JulyCadila Healthcare Ltd may soon start human trials of vaccineCentre tells states to test more as Covid cases surgeThere is no need for another nationwide lockdown: Experts
    Favirpiravir yet to find favour with ICMRAntiviral hyped as potential Covid treatment "ineffective", finds major studyPlasma therapy not promising in initial trials: ICMR officialsBoycott China: Checks on imports to hit drug, devices supply
    Regulate medical devices in phased manner: CompaniesDelhi steps up Covid testing as it tops Mumbai in number of casesIndia Inc sounds out labs for antibody testsA 2000-year-old medicine might find its thunder amidst Covid scare
    Maharashtra asks firms to start antibody tests on their staff, Delhi still to decideNo nod to Patanjali products for Covid treatment: AYUSH ministryBaba Ramdev launches ayurvedic corona treatment; Ministry of Ayush says all claims need to be verifiedLifestyle changes due to lockdown may trigger weight gain and enhanced risk of type 2 diabetes mellitus in healthy people
    Delhi plans sero survey, but one by ICMR not yet revealedEven healthy may turn diabetic due to lockdown: StudyIncrease rapid testing numbers: Delhi High Court to AAP governmentFor Johnson & Johnson, fair isn’t lovely anymore
    Hetero, Cipla to supply generic Remdesivir to hospitals this weekDCGI gives nod to Hetero Labs and Cipla to manufacture and market remdesivirAs local production of PPE suits rises, govt looks to allow exportsICMR sets up 11 teams to monitor antigen tests
    Favipiravir and Remdesivir get approval for treatmentGovt bulk drug scheme may allow exports, tooAny delay in paying salaries of health workers to be an offence now: GovtIndia must manufacture more APIs locally, depend less on China: Experts
    Patients recovered from Covid-19 to get fitness certificates‘India not to stop hydroxychloroquine treatment in mild cases'How hotspot Mumbai, Delhi can bring down mortalityHotel Taj Mansingh to be converted into Covid treatment facility
    ICMR approves antigen test for Covid-19 to ramp up testing on a large scaleAwaiting critical Remdesivir safety data from companies: DCGIFDA revokes emergency use authorization of hydroxychloroquine for COVID-19Patients import Remdesivir even as domestic companies await nod
    Shortage of nurses cripples Mumbai and New Delhi hospitalsCentre on edge as Delhi becomes the new MumbaiExport ban on HCQ could be lifted
    Export ban on HCQ could be lifted
    10 Jun 2020 07:09 AM IST
    Sero survey findings not shared with ICMR’s panel: DCS Reddy
    Private hospitals roll out home care plans for mild Covid patientsTraditional drug companies begin immunity trialsAre we really in a bad Covid spot? You will know this weekRising PPE waste another concern facing AIIMS, now
    As toll rises, shortage of beds is main worry for Mumbai, DelhiOfficial reiterates faith in HCQ, says use recommended after assessmentIndian licensees free to price Remdesivir: GileadSome private hospitals have limitations in boosting Covid care: Max Healthcare chief
    Post Covid, things will pick up where they left off: Abhay Soi, Chairman, Max HealthcareMacleods' HCQ use for staff raises questionsGovt plans survey in worst-hit Mumbai, Delhi & AhmedabadLocal Pharma API companies to gain from Rs 10,000 crore scheme
    Delhi needs additional beds and land for burialGovt didn't take expert advice before imposing lockdown?BDR in pact to make Gilead drug for CiplaSingapore SC dismisses Singh Bros' appeal against HC order
    Plan on cards to keep tabs on migrants going homeTwo govt panels want Covid lockdown liftedRemote control by govt leaves many pvt hospitals with that sinking feelingBDR Pharmaceuticals move on Remdesivir clone irks Gilead
    Talk to labs to cut test costs: Centre directs state governmentsPatients taking HCQ should complete the course: WHOCentre asks states to negotiate with private labs to bring down price of Covid testCovid-19 treatment: Cipla, Hetero Lab get nod to manufacture and sell Remdesivir
    Cipla and Hetero seek clinical trial waiver for RemdesivirICMR clears hydroxychloroquine for wider usage, but with some ridersThe Department of Pharmaceuticals proposes to oversee drug regulatorJohnson and Johnson may scale down talc business in India
    AIIMS to soon conduct 1st autopsy to study virusGovernment to stop daily Covid briefings
    The Economic Times